BTIG Maintains Buy on Globus Medical, Raises Price Target to $77
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Ryan Zimmerman maintains a Buy rating on Globus Medical and raises the price target from $75 to $77.
August 28, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BTIG analyst Ryan Zimmerman has maintained a Buy rating on Globus Medical and increased the price target from $75 to $77, indicating a positive outlook.
The maintenance of a Buy rating and the increase in the price target by a reputable analyst suggests confidence in the company's future performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100